Found 0 matching trials
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
PHASE3This study is designed to compare the efficacy and safety of I-DXd with tre...
Location
Highlands Oncology Group
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
PHASE1This is a first-in-human, Phase 1/2, open-label, dose escalation, dose expa...
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS
PHASE2Patients participating in this study have DSRCT that has spread locally or ...
Location
Fondazione del Piemonte per l'Oncologia IRCCS
A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA
N/AThis is an expanded access program in the USA to enable eligible patients w...
Status
Approved For Marketing
Location
Multiple Locations
Clinical Trial of Lurbinectedin (PM01183) in Patients With Advanced Solid Tumors
PHASE1Prospective, open-label, two-way crossover, phase Ib drug-drug interaction ...
Location
Fundacion Jimenez Diaz
RW Effectiveness of Lurbinectedin in Extensive Stage SCLC
N/ALURBICLIN cohort will describe the demographic and clinical characteristics...
Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC
PHASE1This is a single-arm, phase I/II trial to determine the Maximum Tolerated D...
Location
Advent Health - Celebration
Study of Trilaciclib and Lurbinectidin
PHASE2Lung cancer is by far the leading cause of cancer death among both men and ...
Location
Dartmouth Hitchcock Medical Center
Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors
PHASE1Clinical trial of PM01183 in combination with paclitaxel, with or without b...
Location
Multiple Locations
Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors
PHASE1Phase Ib/II study to evaluate the efficacy and tolerability of PM01183 in c...
Location
Hospital Reina Sofía